Putnam BioRevolution ETF Rating $30.45 +0.03 (+0.10%) As of 08/29/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.75Holdings in SYNB have an aggregate rating of Moderate Buy based on 350 analyst ratings issued in the past year covering 21 companies (80.7% of the portfolio).SYNB Aggregate Price Target$30.45High Prediction$30.45Average Prediction$30.45Low Prediction$30.45Holdings in SYNB have an aggregate price target of $30.45 and a range of $30.45 to $30.45 covering 21 companies (80.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.15%TMOThermo Fisher Scientific$493.05+0.7%4.9434 of 5 stars2.73$593.00 20.3%22Positive NewsAnalyst UpgradeInsider Trade5.98%CTVACorteva$74.22-0.1%4.4839 of 5 stars2.87$80.25 8.1%15Positive News5.20%NVZMYNovozymes A/S$64.20-0.8%3.2265 of 5 stars2.754News CoverageDividend CutGap Down5.15%ABBVAbbVie$210.25+1.1%4.7619 of 5 stars2.92$214.95 2.2%26Trending News4.79%NVDANVIDIA$174.18-3.3%4.9374 of 5 stars2.93$207.69 19.2%43Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision4.62%ASNDAscendis Pharma A/S$194.27+0.2%3.3804 of 5 stars3.00$243.36 25.3%15Positive News4.46%BIOBio-Rad Laboratories$298.39+1.6%4.3823 of 5 stars2.60$333.50 11.8%5Positive NewsAnalyst Upgrade4.38%AZNAstraZeneca$79.90-0.1%2.9165 of 5 stars2.80$86.00 7.6%5Positive News4.05%CDNSCadence Design Systems$350.43-1.1%4.3967 of 5 stars2.73$364.33 4.0%15Positive News3.53%ICLRIcon$177.94+1.7%4.046 of 5 stars2.75$218.38 22.7%163.36%DDDuPont de Nemours$77.02-0.8%4.5153 of 5 stars2.75$88.25 14.6%12News CoveragePositive News3.34%ZTSZoetis$156.45+1.1%4.9045 of 5 stars2.50$202.43 29.4%8Trending NewsAnalyst Revision3.22%DHRDanaher$206.09+0.4%4.9182 of 5 stars2.85$247.61 20.1%20Positive News3.14%LLYEli Lilly and Company$732.41+0.1%5 of 5 stars2.67$950.17 29.7%24Trending NewsAnalyst Upgrade3.07%REGNRegeneron Pharmaceuticals$580.70+0.2%4.7844 of 5 stars2.81$817.67 40.8%27Trending NewsAnalyst Forecast2.90%NGVTIngevity$58.32+0.6%1.7054 of 5 stars2.50$55.00 -5.7%2News CoveragePositive News2.64%DARDarling Ingredients$33.94-1.1%4.9167 of 5 stars2.78$43.57 28.4%9Positive News2.51%TECHBio-Techne$54.63+0.6%4.9731 of 5 stars2.69$69.42 27.1%13Positive News2.16%AVTRAvantor$13.48+2.0%4.4763 of 5 stars2.47$15.50 15.0%15Positive News2.09%BIIBBiogen$132.22-0.3%4.8594 of 5 stars2.34$185.74 40.5%32Positive News1.91%ONONON$45.05+1.0%4.4491 of 5 stars2.91$64.20 42.5%22Positive News This page (NYSEARCA:SYNB) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYNB Stock Alerts